Integrated Diagnostics Holdings
Financial ratios & Valuation

Forward Multiples (2025 – 2027)

202520262027
Price/Earnings ratio
1.050.81N/A
Price/Sales ratio
0.190.170.12
Earnings per Share (EPS)
$1.21$1.58N/A

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
45.2340.0834.9933.1022.1918.7817.438.5417.3512.870.3818.78
Price/Sales ratio
6.985.727.788.175.804.313.892.312.601.590.064.31
Price/Book Value ratio
3.313.064.075.514.904.334.564.674.362.450.144.33
Price/Cash Flow ratio
19.9130.5922.8530.7120.0313.7611.735.3144.9912.080.3913.76
Price/Free Cash Flow ratio
26.6343.0326.0250.3849.5820.0213.686.01-93.8130.170.6620.02
Price/Earnings Growth ratio
0.374.400.410.800.6215.781.050.06-0.28-2.310.0815.78
Dividend Yield
3.82%0.11%0.97%3.04%3.90%4.69%4.35%3.96%15.03%N/AN/A4.69%
Profitability Indicator Ratios
Gross Profit Margin
44.25%53.93%53.64%48.17%49.35%48.67%50.54%53.66%40.55%36.97%42.71%48.67%
Operating Profit Margin
28.49%26.35%39.82%35.68%35.64%35.51%37.10%43.29%32.49%17.89%28.58%35.51%
Pretax Profit Margin
28.11%27.04%33.19%36.87%37.33%34.05%36.48%42.72%23.67%17.88%26.50%34.05%
Net Profit Margin
15.43%14.27%22.24%24.70%26.13%22.94%22.36%27.03%15.00%12.37%16.81%22.94%
Effective Tax Rate
41.42%43.54%31.30%31.28%30.73%33.45%37.10%33.14%38.31%36.48%33.73%30.73%
Return on Assets
5.94%5.83%8.54%12.01%14.62%13.60%14.21%22.65%10.21%8.84%14.36%13.60%
Return On Equity
7.32%7.64%11.63%16.65%22.11%23.06%26.16%54.69%25.12%19.04%31.79%22.11%
Return on Capital Employed
12.42%12.48%18.18%20.57%24.77%27.01%31.10%58.19%30.57%16.41%35.95%24.77%
Liquidity Ratios
Current Ratio
N/A1.582.032.011.571.251.34N/AN/AN/A0.941.25
Quick Ratio
1.311.481.921.871.441.151.241.200.921.240.431.15
Cash ratio
0.961.131.411.410.610.490.590.370.440.520.330.49
Days of Sales Outstanding
31.7936.3534.4237.9542.9042.8944.9026.1140.2450.59N/A42.89
Days of Inventory outstanding
27.4026.7934.7832.5234.1626.9327.8133.5645.2152.6339.2134.16
Operating Cycle
59.2063.1569.2170.4877.0669.8372.7159.6885.46103.2339.2169.83
Days of Payables Outstanding
45.1755.2284.7958.6759.2246.3749.3446.9445.9538.1733.4446.37
Cash Conversion Cycle
14.027.92-15.5811.8117.8423.4523.3712.7439.5165.05-23.7723.45
Debt Ratios
Debt Ratio
0.00N/A-0.060.010.030.020.020.010.020.010.560.03
Debt Equity Ratio
0.00N/A-0.080.020.050.040.040.030.050.041.430.05
Long-term Debt to Capitalization
N/AN/AN/A0.010.040.030.020.020.040.020.030.03
Total Debt to Capitalization
0.00N/A-0.090.020.050.040.030.030.050.030.040.04
Interest Coverage Ratio
N/A49.4650.6252.2758.5813.1015.14N/AN/AN/A10.4713.10
Cash Flow to Debt Ratio
6.70KN/A-2.017.604.386.539.4823.141.794.898.354.38
Company Equity Multiplier
1.231.311.361.381.511.691.842.412.452.152.541.51
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.350.180.340.260.280.310.330.430.050.130.160.31
Free Cash Flow / Operating Cash Flow Ratio
0.740.710.870.600.400.680.850.88-0.470.400.590.40
Cash Flow Coverage Ratio
6.70KN/A-2.017.604.386.539.4823.141.794.898.354.38
Short Term Coverage Ratio
6.70KN/A-2.0127.6521.8827.4334.72104.509.2012.4439.1121.88
Dividend Payout Ratio
173.01%4.46%34.00%100.72%86.62%88.17%75.87%33.89%260.89%N/AN/A88.17%